Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2872196 | The Annals of Thoracic Surgery | 2015 | 10 Pages |
Abstract
For patients undergoing AVR with a stented bioprosthetic valve, with or without coronary artery bypass grafting, the choice of a porcine vs bovine pericardial bioprosthesis does not appear to affect long-term survival or need for reoperation, regardless of valve size or patient age. As such, stented bioprosthetic valves would appear to be fungible, and therefore, valve choice should be driven by local market factors similar to other commodities.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Asvin M. MD, Brian R. MD, Jeffrey E. MD, Matthew A. MD, Hanghang MD, Peter K. MD, Donald D. MD, G. Chad MD,